Abstract
This new treatment for an old disease has its origins in pharmacological research of the late 1950s. There is still not full agreement about how L-dopa functions in the nervous system, but, as this review shows, there is ample evidence to support the clinical work in progress since 1961.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ehringer, H., and Hornykiewicz, O., Klin. Wschr., 38, 1236 (1960).
Hornykiewicz, O., Pharmacol. Revs., 18, 925 (1966).
Bernheimer, H., Birkmayer, W., and Hornykiewicz, O., Wien. Klin. Wschr., 78, 417 (1966).
Guldberg, H., Turner, J., Hanieh, A., Ashcroft, G., Crawford, T. B. B., and Gillingham, F. J., Confin. Neurol, 29, 73 (1967).
Johansson, B., and Roos, B.-E., Life Sci., 6, 1449 (1967).
Blaschko, H., Experientia, 13, 9 (1957).
Carlsson, A., Pharmacol. Rev., 11, 490 (1959).
Hillarp, N.-Å, Fuxe, K., and Dahlström, A., in Mechanisms of Release of Biogenic Amines (edit. by von Euler, U. S., Rosell, S., and Uvnäs, B.), 5, 31, Wenner-Gren Centre International Symposium Series (Pergamon, Oxford, 1966).
Hökfelt, T., Z. Zellforsch., 91, 1 (1968).
Poirier, L. J., and Sourkes, T. L., Brain, 88, 181 (1965).
McLennan, H., Experientia, 21, 725 (1965).
Portig, P. J., and Vogt, M., J. Physiol. 204, 687 (1969).
Bloom, F. E., Costa, E., and Salmoiraghi, G. C., J. Pharmacol. Exp. Ther., 150, 244 (1965).
McLennan, H., and York, D. H., J. Physiol., 189, 393 (1967).
Connor, J. D., Science, 160, 899 (1968).
Feltz, P., J. Physiol., 205, 8P (1969).
McLennan, H., and York, D. H., J. Physiol., 187, 163 (1966).
Gallindo, A., Krnjevic, K., and Schwartz, S., J. Physiol., 192, 359 (1967).
McGeer, P. L., Boulding, J. E., Gibson, W. C., and Foulkes, R. G., J. Amer. Med. Assoc., 177, 665 (1961).
Barbeau, A., Canad. Med. Ass. J., 87, 802 (1962).
Arvidsson, J., Roos, B.-E., and Steg, G., Acta Physiol. Scand., 67, 398 (1966).
Duvoisin, R., Arch. Neurol., 17, 124 (1967).
Coyle, J. T., and Snyder, S. H., Science, 166, 899 (1969).
Blaschko, H., J. Physiol., 96, 50P (1939).
Udenfriend, S., Pharmacol. Rev., 18, 43 (1966).
Nagatsu, T., Levitt, M., and Udenfriend, S., J. Biol. Chem., 239, 2910 (1964).
Peters, D. A. V., McGeer, P. L., and McGeer, E. G., J. Neurochem., 15, 1431 (1968).
Sourkes, T. L., Pharmacol. Rev., 18, 53 (1966).
Coulson, W. F., Bender, D. A., and Jepson, J. B., Biochem. J., 115, 63P (1969).
Robins, E., Robins, J. M., Croninger, A. B., Moses, S. G., Spencer, S. J., and Hudgens, R. W., Biochem. Med., 1, 240 (1967).
Calne, D. B., Karoum, F., Ruthven, C. R. J., and Sandler, M., Brit. J. Pharmacol., 37, 57 (1969).
Tissot, R., Bartholini, G., and Pletscher, A., Arch. Neurol., 20, 187 (1969).
Holtz, P., Pharmacol. Rev., 11, 317 (1959).
Weil-Malherbe, H., in Adrenergic Mechanisms (edit. by Vane, J. B., Wolstenholme, G. E. W., and O'Connor, M.), 421 (Churchill, London, 1960).
Ernst, A. M., Acta Physiol. Pharmacol. Neerl., 15, 141 (1969).
Cotzias, G. C., Papavasiliou, P. S., Fehling, C., Kaufman, B., and Mena, I., New Engl. J. Med., 282, 31 (1970).
Tissot, R., Gaillard, J. M., Guggisberg, M., Gauthier, G., and de Ajuriaguerra, J., Presse Méd., 77, 619 (1969).
Bartholini, G., and Pletscher, A., J. Pharmacol. Exp. Ther., 161, 14 (1968).
Levin, E. Y., Levenberg, B., and Kaufman, S., J. Biol. Chem., 235, 2080 (1960).
Goodall, McC., and Alton, H., J. Clin. Invest., 48, 2300 (1969).
Kirshner, N., Pharmacol. Rev., 11, 350 (1959).
Hornykiewicz, O., Davidson, L., and Kraster, F., Proc. Fourth Intern. Cong. Pharmacol., Basle, 71 (1969).
Hornykiewicz, O., Proc. Second Intern. Pharmacol. Meeting, Prague (edit. by Raskova, H.), 2, 57 (Pergamon, Oxford, 1964).
Sandler, M., and Ruthven, C. R. J., in Progress in Medicinal Chemistry (edit. by Ellis, G. P., and West, G. B.), 6, 200 (Butterworth, London, 1969).
Weiner, N., Arch. Biochem. Biophys., 91, 182 (1960).
Collins, G. G. S., Sandler, M., Williams, E. D., and Youdim, M. B. H., Nature, 225, 817 (1970).
Barbeau, A., and Duchastel, Y., Canad. Psychiat. Assoc. J., 7, 591 (1962).
Karoum, F., Ruthven, C. R. J., and Sandler, M., Clin. Chim. Acta, 20, 427 (1968).
Karoum, F., Anah, C. O., Ruthven, C. R. J., and Sandler, M., Clin. Chim. Acta, 24, 341 (1969).
Sandler, M., Karoum, F., Ruthven, C. R. J., and Calne, D. B., Science, 166, 1417 (1969).
Blaschko, H., and Chrusciel, T. L., J. Physiol., 151, 272 (1960).
Shulgin, A. T., Sargent, T., and Naranjo, C., Nature, 221, 537 (1969).
Sandler, M., Proc. Laurentian Meeting on Dopa in Parkinsonism (in the press).
Senoh, S., Creveling, C. R., Udenfriend, S., and Witkop, B., J. Amer. Chem. Soc., 81, 6236 (1959).
Thoenen, H., and Tranzer, J. P., Naunyn-Schmiedebergs Arch. Pharmak., 261, 271 (1968).
Ungerstedt, U., Europ. J. Pharmacol., 5, 107 (1968).
Calne, D. B., Brennan, J., Spiers, A. S. D., and Stern, G. M., Brit. Med. J., 1, 474 (1970).
Shy, G. M., and Drager, G. A., Arch. Neurol., 2, 511 (1960).
Goldstein, M., Battista, A. F., Nakatani, S., and Anagnoste, B., Nature, 224, 382 (1969).
Mena, I., Court, J., Fuenzalida, S., Papavasiliou, P. S., and Cotzias, G. C., New Engl. J. Med., 282, 5 (1970).
Birkmayer, W., and Hornykiewicz, O., Wien Klin. Wschr., 73, 787 (1961).
Barbeau, A., Canad. Med. Assoc. J., 101 791 (1969).
Cotzias, G. C., Van Woert, M. H., and Schiffer, L. M., New Engl. J. Med., 276, 374 (1967).
Cotzias, G. C., Papavasiliou, P. S., Gellene, R., and Aronson, R. B., Trans. Assoc. Amer. Physicians, 81, 171 (1968).
Cotzias, G. C., Papavasiliou, P. S., and Gellene, R., New Engl. J. Med., 280, 337 (1969).
Yahr, M. D., Duvoisin, R. C., Hoehn, M. M., Schear, M. J., and Barrett, B. E., Trans. Amer. Neurol. Assoc., 93, 56 (1968).
Yahr, M. D., Duvoisin, R. C., Schear, M. J., Barrett, R. E., and Hoehn, M. M., Arch. Neurol., 21, 343 (1969).
Calne, D. B., Stern, G. M., Laurence, D. R., Sharkey, J., and Armitage, P., Lancet, i, 744 (1969).
Calne, D. B., Spiers, A. S. D., Stern, G. M., Laurence, D. R., and Armitage, P., Lancet, ii, 973 (1969).
Duvoisin, R. C., in Psychotropic Drugs and Dysfunctions of the Basal Ganglia (edit. by Crane, G. E., and Gardner, R.), 135 (US Govt. Printing Office, Washington, 1969).
Godwin-Austen, R. B., Tomlinson, E. B., Frears, C. C., and Kok, H. W. L., Lancet, ii, 165 (1969).
McDowell, F., Lee, J. E., Swift, T., Sweet, R. D., Ogsbury, J. S., and Kessler, J. J., Ann. Intern. Med., 72, 29 (1970).
Mawdsley, C., Brit. Med. J., 1, 331 (1970).
Peaston, M. J. T., and Bianchine, J. B., Brit. Med. J., 1, 400 (1970).
Neff, N. H., Barrett, R. E., and Costa, E., Experientia, 25, 1140 (1969).
Ansel, R. D., Proc. Laurentian Meeting on Dopa in Parkinsonism (in the press).
Bartholini, G., Pletscher, A., and Burkhard, W. P., J. Pharm. Pharmacol., 20, 228 (1968).
Schwab, R. S., England, A. C., Poskanzer, D. C., and Young, R. R., J. Amer. Med. Assoc., 208, 1168 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
CALNE, D., SANDLER, M. L-Dopa and Parkinsonism. Nature 226, 21–24 (1970). https://doi.org/10.1038/226021a0
Issue Date:
DOI: https://doi.org/10.1038/226021a0
This article is cited by
-
Levodopa in Mucuna pruriens and its degradation
Scientific Reports (2015)
-
Pyridoxal 5?-phosphate levels in brain after treatments which impair cerebral glucose metabolism
Neurochemical Research (1979)
-
Amantadine antagonism of oxotremorine effects
Journal of Neural Transmission (1979)
-
Asymmetric synthesis of amino acids by the catalytic reduction of azlactones using substituted acylaminoacrylic acids 3. Production of 3,4-dihydroxyphenylalanine
Bulletin of the Academy of Sciences of the USSR Division of Chemical Science (1978)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.